SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS A major partnership to accelerate Safe's development in the Spanish market Fleurieux-sur-l’Arbresle – France – December 17, 2025 – 8am - Safe (FR001400ZU25 – ALSAF) announces the signing of an exclusive distribution agreement with Vortrom Biologics, a subsidiary of Vortrom, for the Spanish market. A strategic partnership with a leading player For more than 40 years, Vortrom, a major distributor of medical equipment in Spain, is no ...

公司业务动态 - GE HealthCare宣布将向印度尼西亚供应超过300台CT扫描仪 [1] - 该供应合同是印度尼西亚加强卫生转诊网络计划的一部分 [1] - 合同是通过竞争性招标获得的一份多年期协议 [1] 市场与订单详情 - 供应的先进CT扫描仪将覆盖印度尼西亚全部38个省份的公立医院 [1] - 覆盖范围包括城市和偏远地区 [1] - 该计划旨在为超过2.8亿印度尼西亚人提供公平、高质量的医疗服务 [1]

Accuray Incorporated (NASDAQ:ARAY) announced the first phase of a broad strategic, operational and organizational transformation designed to tighten cost controls, clarify accountability and accelerate execution, with management targeting a meaningful improvement in profitability once the changes are fully implemented. • Accuray stock is trending lower. What’s pulling ARAY shares down?The initial phase of the plan focuses on reshaping the company's operating model to support faster decision-making and stron ...

公司表现 - 德康公司作为医疗设备市场的大型股代表 在2025年迄今为止未能为股东带来理想的回报 [1] 行业状况 - 整个医疗设备行业在2025年表现同样不佳 [1]

Accuray expects to give further updates concerning its transformation plan from time to time as material developments occur. "As a team, we are laser focused on a clear corporate, product and service strategy, and the phase one initiatives, which have been driven by the transformation leaders we announced at the time of our first fiscal quarter earnings release, are designed to set the stage for that strategy. The changes sharpen our focus on sales and service in every region around the world, establish a f ...

Louvain-La-Neuve, Belgium, December 15, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, is pleased to share today that, on December 11, The Lancet – one of the world’s most renowned academic journals – published a landmark study that recommends proton therapy as a new standard of care for patients with oropharyngeal cancer. This study, led by MD Anderson Cancer C ...

Financial giants have made a conspicuous bullish move on Intuitive Surgical. Our analysis of options history for Intuitive Surgical (NASDAQ:ISRG) revealed 9 unusual trades.Delving into the details, we found 55% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $237,010, and 3 were calls, valued at $94,205.Projected Price TargetsBased on the trading activity, it appears that the significant investors are aiming for a price territory s ...

Pzena Investment Management recently released its third-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. Driven by optimism about AI and a September rate cut, US broad-based indexes surged in the third quarter. The technology sector was the strongest performer, with growth outpacing value. The Pzena Focused Value strategy gained but underperformed the Russell 1000 Value Index, returning 1.1% gross and 0.9% net vs. 5.3% for the index. In addition, pleas ...

UPPSALA, SE / ACCESS Newswire / December 9, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ.) today announced that one of the leading NHS hospital trusts in the United Kingdom (UK) has ordered a total of 70 TetraGraph systems to standardize neuromuscular monitoring across all major operating rooms. ...

Louvain-La-Neuve, Belgium, December 8, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, announces today it has signed a contract with YAS Healthcare, a subsidiary of DAS Holding, to install a Proteus®ONE1 compact proton therapy solution to be located in Dubai, United Arab Emirates (UAE). With the acquisition of this Proteus®ONE system, YAS Healthcare will establi ...